A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure.
de Denus S, Dubé MP, Fouodjio R, Huynh T, LeBlanc MH, Lepage S, Sheppard R, Giannetti N, Lavoie J, Mansour A, Provost S, Normand V, Mongrain I, Langlois M, O'Meara E, Ducharme A, Racine N, Guertin MC, Turgeon J, Phillips MS, Rouleau JL, Tardif JC, White M; CANDIID II investigators.
de Denus S, et al. Among authors: normand v.
Pharmacogenomics. 2018 May;19(7):599-612. doi: 10.2217/pgs-2018-0004. Epub 2018 Apr 27.
Pharmacogenomics. 2018.
PMID: 29701105
Clinical Trial.